Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market

* Sunshine Biopharma's Amoxicillin now shipping to Canadian pharmacies in multiple dosages and strengths * Launch expands Sunshine Biopharma's growing portfolio of essential prescription medications * Global Amoxicillin market projected to reach approximately $6.4 billion by 2031

FORT LAUDERDALE, FL / ACCESS Newswire / August 7, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the launch of its generic Amoxicillin formulation in the Canadian market. This strategic expansion reinforces Sunshine Biopharma's commitment to providing affordable, high-quality antibiotics to patients across Canada.